Hydroxychloroquine Blocks SARS-COV-2 Entry (New in-vitro study)
Supported by NIH and The US Department of Defense, this new study reveals an unknown mechanism of hydroxychloroquine to block the endocytic entry of SARS-COV-2. Let’s review.
Keep in mind that this is an in-vitro, peer-reviewed, accepted, and published study.
If you like this content and want more, I am doing a special lifetime membership offer. Click here:
Want to support this work?:
Buy me a coffee 🙂 https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
My substack: https://mobeensyedmd.substack.com/
#drbeen #koolbeens #COVID
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Monday, Sep. 19 2022
Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture | Communications Biology
Cathepsins: Proteases that are vital for survival but can also be fatal – PMC
The ganglioside GM1 interacts with the serotonin1A receptor via the sphingolipid binding domain – ScienceDirect
Phosphatidylinositol 4,5-bisphosphate – Wikipedia
Review of PIP2 in Cellular Signaling, Functions and Diseases – PMC